Sequences Of REGorafenib And Trifluridine/Tipiracil in Patients With Metastatic Colorectal Cancer
Status:
Recruiting
Trial end date:
2028-05-23
Target enrollment:
Participant gender:
Summary
A randomized, phase II study comparing the sequences of regorafenib and
trifluridine/tipiracil, after failure of standard therapies in patients with metastatic
colorectal cancer